Articles

NBE-Therapeutics Articles

September 10, 2020PharmabizNews

Exelixis, NBETherapeutics partner to develop novel antibodydrug conjugates for cancer treatment

Exelixis, Inc., an oncology─focused biotechnology company, and NBE─Therapeutics, a privately─owned Sw... See more »
September 9, 2020ZacksNews

Exelixis Inks a Couple of Deals to Develop Novel ADCs for Cancer

Exelixis (EXEL) signs a collaboration agreement with private biotech NBE-Therapeutics for developing ... See more »
September 9, 2020startuptickerNews

NBE-Therapeutics receives USD 25 million upfront payment

Swiss biotech NBE-Therapeutics and Exelixis have inked a partnership to develop novel antibody-drug c... See more »
November 7, 2019startuptickerNews

SOTIO expands collaboration with NBE Therapeutics

In 2016 SOTIO and NBE Therapeutics have entered into a partnership. The two companies will now develo... See more »
October 29, 2019startuptickerNews

Biotech startups strengthen their teams

Cutiss, NBE Therapeutics and Stalicla have grown their teams. As per October, the newly appointed mem... See more »
April 15, 2019Manufacturing ChemistNews

Swiss NBE-Therapeutics chooses WuXi Biologics as manufacturing partner

Chinese-Swiss partnership will focus on developing and manufacturing anti-ROR1 ADC products for clini... See more »
March 13, 2019BioPortfolioNews

NBE to Present LateBreaking Abstract on Lead ADC Program NBE002 ROR1 at the AACR Annual Meeting

BASEL Switzerland March 13 2019 B3C newswire NBETherapeutics AG a biopharmaceutical company developin... See more »
November 15, 2018BioPortfolioNews

Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBETherapeutics

Basel Switzerland November 15 2018 B3C newswire NBE Therapeutics AG a biopharmaceutical company devel... See more »
October 1, 2018BioPortfolioNews

NBETherapeutics AG Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

SummaryNBETherapeutics AG NBETherapeutics is a biotechnology company that focuses on the development ... See more »
July 28, 2018BioPortfolioNews

NBETherapeutics AG Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250

SummaryNBETherapeutics AG NBETherapeutics is a biotechnology company that focuses on the development ... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...